New Antipsychotics and Schizophrenia: A Review on Efficacy and Side Effects
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
343-358
Author(s):
Alessandro Serretti, Diana De Ronchi, Cristina Lorenzi and Domenico Berardi
The NMDA Receptor NR2B Subunit: A Valid Therapeutic Target for Multiple CNS Pathologies
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
389-396
Author(s):
Paul L. Chazot
Preface [Hot topic: Potential Therapeutic Agents for Parkinsons Disease (Executive Editor: Masato Asanuma)]
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
668-668
Author(s):
Masato Asanuma
Novel Therapeutic Effects of the Anti-Convulsant, Zonisamide, on Parkinsons Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
687-693
Author(s):
M. Murata
Neurokinin Peptides and Neurokinin Receptors as Potential Therapeutic Intervention Targets of Basal Ganglia in the Prevention and Treatment of Parkinsons Disease
Journal:
Current Drug Targets
Volume:
5
Page:
197-206
Author(s):
L.- W. Chen, K. K.L. Yung and Y S Chan
Molecular Genetic of Human Male Infertility: From Genes to New Therapeutic Perspectives
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
471-500
Author(s):
Peter H. Vogt
Recent Evidence Regarding a Role for Cdk5 Dysregulation in Alzheimers Disease
Journal:
Current Alzheimer Research
Volume:
1
Page:
33-38
Author(s):
E. A. Monaco III
5-HT2 Receptors
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
11-26
Author(s):
J E Leysen
Neuropharmacology of Cannabinoid System: From Basic Science to Clinical Applications
Journal:
Current Neuropharmacology
Volume:
2
Page:
1-7
Author(s):
F. R. Buttarelli, F. R. Patacchioli, G. Palladini, E. Brunetti and F. E. Pontieri
Nicotine and Nicotinic Receptor Involvement in Neuropsychiatric Disorders
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
267-282
Author(s):
P. Newhouse, A. Singh and and A. Potter